Spire Wealth Management Prothena Corp Public LTD CO Transaction History

Spire Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$30.27 - $49.22 $32,388 - $52,665	-1,070 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$42.11 - $73.26 $40,720 - $70,842	967 Added 938.83%	1,070 $53,000
Q3 2021 Oct 22, 2021	BUY	$48.2 - $78.89 $4,964 - $8,125	103 New	103 $7,000
Q2 2021 Jul 26, 2021	SELL	$21.63 - $57.65 $23,100 - $61,570	-1,068 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$11.0 - $28.24 $11,748 - $30,160	1,068 New	1,068 $29,000

184

42.7M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $641M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.